N-(4-hydroxyphenyl) retinamide augments laser-induced choroidal neovascularization in mice

Invest Ophthalmol Vis Sci. 2008 Mar;49(3):1210-20. doi: 10.1167/iovs.07-0667.

Abstract

Purpose: To evaluate the effect of N-4-hydroxyphenyl retinamide (4-HPR) on experimental laser-induced choroidal neovascularization (CNV) and on the expression and secretion of relevant growth factors by cultured human retinal pigment epithelial (RPE) cells.

Methods: CNV was induced by laser photocoagulation in C57BL/6 mice. 4-HPR (0.2 or 1 mg) or vehicle, was injected intraperitoneally twice daily for 14 days. Plasma and tissue levels of 4-HPR were measured by HPLC. CNV was evaluated by fluorescein angiography, histology, and quantitative confocal analysis of isolectin B4 histochemistry on days 7 and 14. Induction of apoptosis and expression and secretion of growth factors was studied in 4-HPR-treated RPE cultures.

Results: Mice treated with 4-HPR exhibited time- and dose-dependent increases in plasma and tissue 4-HPR levels. CNV lesions showed increased volume with increased vascular leakage and contained fewer lesion-associated RPE in treated versus untreated mice. Treatment of nonpolarized RPE cultures with 4-HPR in the presence of serum resulted in RPE apoptosis; however, apoptosis was minimal in similarly treated highly polarized RPE. Treatment of RPE cells with 4-HPR resulted in the upregulation of VEGF-A and -C (P < 0.05) and Ang-1 (P < 0.01) mRNA and increased secretion of VEGF-A and -C (P < 0.05), whereas pigment epithelium-derived growth factor (PEDF) and thrombospondin (TSP)-1 mRNA expression and secretion were downregulated (P < 0.05).

Conclusions: 4-HPR increases lesion size and leakage in laser-induced CNV and is associated with the upregulation of key proangiogenic factors and the downregulation of antiangiogenic factors. Consistent with the preferential loss of RPE in CNV lesions in vivo, 4-HPR induces apoptosis of nonpolarized RPE in the presence of serum.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inducing Agents / pharmacokinetics
  • Angiogenesis Inducing Agents / pharmacology*
  • Angiopoietin-1 / genetics
  • Angiopoietin-1 / metabolism
  • Animals
  • Apoptosis / drug effects
  • Blotting, Western
  • Cells, Cultured
  • Choroid / drug effects*
  • Choroid / pathology
  • Choroidal Neovascularization / etiology*
  • Choroidal Neovascularization / metabolism
  • Choroidal Neovascularization / pathology
  • Disease Models, Animal*
  • Dose-Response Relationship, Drug
  • Enzyme-Linked Immunosorbent Assay
  • Eye Proteins / genetics
  • Eye Proteins / metabolism
  • Fenretinide / pharmacokinetics
  • Fenretinide / pharmacology*
  • Fluorescein Angiography
  • In Situ Nick-End Labeling
  • Injections, Intraperitoneal
  • Laser Coagulation*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nerve Growth Factors / genetics
  • Nerve Growth Factors / metabolism
  • Pigment Epithelium of Eye / drug effects
  • Pigment Epithelium of Eye / metabolism
  • Pigment Epithelium of Eye / pathology
  • RNA, Messenger / metabolism
  • Serpins / genetics
  • Serpins / metabolism
  • Thrombospondin 1 / genetics
  • Thrombospondin 1 / metabolism
  • Time Factors
  • Up-Regulation
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor C / genetics
  • Vascular Endothelial Growth Factor C / metabolism

Substances

  • Angiogenesis Inducing Agents
  • Angiopoietin-1
  • Angpt1 protein, mouse
  • Eye Proteins
  • Nerve Growth Factors
  • RNA, Messenger
  • Serpins
  • Thrombospondin 1
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor C
  • pigment epithelium-derived factor
  • vascular endothelial growth factor A, mouse
  • vascular endothelial growth factor C, mouse
  • Fenretinide